Key result
Atrial fibrillation will affect approximately 4% of Americans aged 65 and 15% at age 75, emphasizing the growing need for cost-effective stroke prevention strategies such as warfarin.
No takes yet. Share an insight, caveat, or question.
Highlights the growing epidemic of atrial fibrillation in the aging population and the need for simple, cost-effective stroke prevention strategies.
Michael D. Ezekowitz (1999) conducted an editorial in Atrial fibrillation. Warfarin was evaluated. Atrial fibrillation will affect approximately 4% of Americans aged 65 and 15% at age 75, emphasizing the growing need for cost-effective stroke prevention strategies such as warfarin.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: